132 related articles for article (PubMed ID: 18362427)
1. Elevated levels of both cardiomyocyte membrane and myofibril damage markers predict adverse outcomes in patients with chronic heart failure.
Setsuta K; Seino Y; Kitahara Y; Arau M; Ohbayashi T; Takano T; Mizuno K
Circ J; 2008 Apr; 72(4):569-74. PubMed ID: 18362427
[TBL] [Abstract][Full Text] [Related]
2. Heart-type fatty acid-binding protein is more sensitive than troponin T to detect the ongoing myocardial damage in chronic heart failure patients.
Niizeki T; Takeishi Y; Arimoto T; Takabatake N; Nozaki N; Hirono O; Watanabe T; Nitobe J; Harada M; Suzuki S; Koyama Y; Kitahara T; Sasaki T; Kubota I
J Card Fail; 2007 Mar; 13(2):120-7. PubMed ID: 17395052
[TBL] [Abstract][Full Text] [Related]
3. Prognostic value of myocardial damage markers in patients with chronic heart failure with atrial fibrillation.
Otaki Y; Arimoto T; Takahashi H; Kadowaki S; Ishigaki D; Narumi T; Honda Y; Iwayama T; Nishiyama S; Shishido T; Miyashita T; Miyamoto T; Watanabe T; Kubota I
Intern Med; 2014; 53(7):661-8. PubMed ID: 24694473
[TBL] [Abstract][Full Text] [Related]
4. Serum myeloperoxidase level is associated with heart-type fatty acid-binding protein but not troponin T in patients with chronic heart failure.
Gedikli O; Kiris A; Hosoglu Y; Karahan C; Kaplan S
Med Princ Pract; 2015; 24(1):42-6. PubMed ID: 25402608
[TBL] [Abstract][Full Text] [Related]
5. Heart-Type Fatty Acid Binding Protein, Cardiovascular Outcomes, and Death: Findings From the German CKD Cohort Study.
Schneider MP; Schmid M; Nadal J; Wanner C; Krane V; Floege J; Saritas T; Busch M; Sitter T; Friedrich N; Stockmann H; Meiselbach H; Nauck M; Kronenberg F; Eckardt KU;
Am J Kidney Dis; 2022 Oct; 80(4):483-494.e1. PubMed ID: 35288215
[TBL] [Abstract][Full Text] [Related]
6. The use of human heart-type fatty acid-binding protein as an early diagnostic biochemical marker of myocardial necrosis in patients with acute coronary syndrome, and its comparison with troponin-T and creatine kinase-myocardial band.
Ruzgar O; Bilge AK; Bugra Z; Umman S; Yilmaz E; Ozben B; Umman B; Meric M
Heart Vessels; 2006 Sep; 21(5):309-14. PubMed ID: 17151819
[TBL] [Abstract][Full Text] [Related]
7. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes.
O'Donoghue M; de Lemos JA; Morrow DA; Murphy SA; Buros JL; Cannon CP; Sabatine MS
Circulation; 2006 Aug; 114(6):550-7. PubMed ID: 16880323
[TBL] [Abstract][Full Text] [Related]
8. Different characteristics of cardiac biomarkers to decide and predict the culprit lesions in patients with suspicious acute coronary syndrome.
Kitamura M; Hata N; Takayama T; Hirayama A; Ogawa M; Yamashina A; Mera H; Yoshino H; Nakamura F; Seino Y
Heart Vessels; 2016 Jun; 31(6):907-17. PubMed ID: 26081026
[TBL] [Abstract][Full Text] [Related]
9. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure.
Goto T; Takase H; Toriyama T; Sugiura T; Sato K; Ueda R; Dohi Y
Heart; 2003 Nov; 89(11):1303-7. PubMed ID: 14594884
[TBL] [Abstract][Full Text] [Related]
10. Risk stratification of chronic heart failure patients by multiple biomarkers: implications of BNP, H-FABP, and PTX3.
Ishino M; Takeishi Y; Niizeki T; Watanabe T; Nitobe J; Miyamoto T; Miyashita T; Kitahara T; Suzuki S; Sasaki T; Bilim O; Kubota I
Circ J; 2008 Nov; 72(11):1800-5. PubMed ID: 18832778
[TBL] [Abstract][Full Text] [Related]
11. Persistently increased serum concentration of heart-type fatty acid-binding protein predicts adverse clinical outcomes in patients with chronic heart failure.
Niizeki T; Takeishi Y; Arimoto T; Nozaki N; Hirono O; Watanabe T; Nitobe J; Miyashita T; Miyamoto T; Koyama Y; Kitahara T; Suzuki S; Sasaki T; Kubota I
Circ J; 2008 Jan; 72(1):109-14. PubMed ID: 18159110
[TBL] [Abstract][Full Text] [Related]
12. [Heart fatty acid binding protein in patients hospitalized because of worsening heart failure. Relation to prognosis of death].
Mazovets OL; Trifonov IR; Katrukha AG; Bereznikova AV; Medvedeva MV; Deev AD; Gratsianksiĭ NA
Kardiologiia; 2008; 48(1):24-9. PubMed ID: 18260992
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of elevated circulating heart-type fatty acid binding protein in patients with congestive heart failure.
Arimoto T; Takeishi Y; Shiga R; Fukui A; Tachibana H; Nozaki N; Hirono O; Nitobe J; Miyamoto T; Hoit BD; Kubota I
J Card Fail; 2005 Feb; 11(1):56-60. PubMed ID: 15704065
[TBL] [Abstract][Full Text] [Related]
14. Circulating levels of myocardial proteins predict future deterioration of congestive heart failure.
Sugiura T; Takase H; Toriyama T; Goto T; Ueda R; Dohi Y
J Card Fail; 2005 Sep; 11(7):504-9. PubMed ID: 16198245
[TBL] [Abstract][Full Text] [Related]
15. N-terminal pro-BNP is a novel biomarker for integrated cardio-renal burden and early risk stratification in patients admitted for cardiac emergency.
Yamashita T; Seino Y; Ogawa A; Ogata K; Fukushima M; Tanaka K; Mizuno K
J Cardiol; 2010 May; 55(3):377-83. PubMed ID: 20350516
[TBL] [Abstract][Full Text] [Related]
16. Circulating heart-type fatty acid binding protein levels predict the occurrence of appropriate shocks and cardiac death in patients with implantable cardioverter-defibrillators.
Daidoji H; Arimoto T; Nitobe J; Tamura H; Kutsuzawa D; Ishigaki D; Ishino M; Takahashi H; Shishido T; Miyashita T; Miyamoto T; Watanabe T; Kubota I
J Card Fail; 2012 Jul; 18(7):556-63. PubMed ID: 22748489
[TBL] [Abstract][Full Text] [Related]
17. Combination of heart-type fatty acid binding protein and brain natriuretic peptide can reliably risk stratify patients hospitalized for chronic heart failure.
Niizeki T; Takeishi Y; Arimoto T; Takahashi T; Okuyama H; Takabatake N; Nozaki N; Hirono O; Tsunoda Y; Shishido T; Takahashi H; Koyama Y; Fukao A; Kubota I
Circ J; 2005 Aug; 69(8):922-7. PubMed ID: 16041160
[TBL] [Abstract][Full Text] [Related]
18. Prognostic value of high-sensitivity C-reactive protein in patients with chronic heart failure.
Xue C; Feng Y; Wo J; Li Y
N Z Med J; 2006 Nov; 119(1245):U2314. PubMed ID: 17146489
[TBL] [Abstract][Full Text] [Related]
19. Use of cytosolic and myofibril markers in the detection of ongoing myocardial damage in patients with chronic heart failure.
Setsuta K; Seino Y; Ogawa T; Arao M; Miyatake Y; Takano T
Am J Med; 2002 Dec; 113(9):717-22. PubMed ID: 12517360
[TBL] [Abstract][Full Text] [Related]
20. Implications of elevated cardiac troponin T in ambulatory patients with heart failure: a prospective analysis.
Hudson MP; O'Connor CM; Gattis WA; Tasissa G; Hasselblad V; Holleman CM; Gaulden LH; Sedor F; Ohman EM
Am Heart J; 2004 Mar; 147(3):546-52. PubMed ID: 14999208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
